Intranasal insulin linked to reduced food intake

Intranasal insulin linked to reduced food intake
Intranasally administered insulin is associated with higher brain energy levels and reduced calorie intake, according to a study published online May 14 in Diabetes.

(HealthDay) -- Intranasally administered insulin is associated with higher brain energy levels and reduced calorie intake, according to a study published online May 14 in Diabetes.

To examine whether intranasal insulin reduced food consumption by increasing neuroenergetic levels, Kamila Jauch-Chara, M.D., from the University of Luebeck in Germany, and colleagues intranasally administered insulin (40 IU) or a placebo (within subject comparison) to 15 young (22 to 28 years of age), healthy, normal-weight men after an overnight fast and then measured cerebral energy metabolism by . At 100 minutes after treatment, the men were allowed to eat freely from a test buffet.

The researchers found that intranasal insulin increased , as determined by increased adenosine triphosphate and phosphocreatine levels, which was associated with a reduction in subsequent free-choice . The authors note that, consistent with this, their previous study showed that higher cerebral energy content was associated with lower .

"Brain energy levels may therefore constitute a predictive value for food intake," Jauch-Chara and colleagues conclude. "Given that the brain synchronizes food intake behavior in dependence of its current energetic status, a future challenge in obesity treatment may be to therapeutically influence cerebral energy homeostasis."

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Diabetes

Copyright © 2012 HealthDay. All rights reserved.

Citation: Intranasal insulin linked to reduced food intake (2012, June 7) retrieved 19 April 2024 from https://medicalxpress.com/news/2012-06-intranasal-insulin-linked-food-intake.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study evaluates intranasal insulin therapy for adults with mild cognitive impairment or Alzheimer's

 shares

Feedback to editors